Abstract
Mesenchymal stromal cells (MSCs) have tremendous potential for use in regenerative medicine due to their multipotency and immune cell regulatory functions. Biomimetic physical forces have been shown to direct differentiation and maturation of MSCs in tissue engineering applications; however, the effect of force on immunomodulatory activity of MSCs has been largely overlooked. Here we show in human bone marrow-derived MSCs that wall shear stress (WSS) equivalent to the fluid frictional force present in the adult arterial vasculature significantly enhances expression of four genes that mediate MSC immune regulatory function, PTGS2, HMOX1, IL1RN, and TNFAIP6. Several mechanotransduction pathways are stimulated by WSS, including calcium ion (Ca2+) flux and activation of Akt, MAPK, and focal adhesion kinase (FAK). Inhibition of PI3K-Akt by LY294002 or Ca2+ signaling with chelators, ion channel inhibitors, or Ca2+ free culture conditions failed to attenuate WSS-induced COX2 expression. In contrast, the FAK inhibitor PF-562271 blocked COX2 induction, implicating focal adhesions as critical sensory components upstream of this key immunomodulatory factor. In co-culture assays, WSS preconditioning stimulates MSC anti-inflammatory activity to more potently suppress TNF-α production by activated immune cells, and this improved potency depended upon the ability of FAK to stimulate COX2 induction. Taken together, our data demonstrate that biomechanical force potentiates the reparative and regenerative properties of MSCs through a FAK signaling cascade and highlights the potential for innovative force-based approaches for enhancement in MSC therapeutic efficacy.
Keywords: Anti-inflammatory, COX2, FAK, Immunomodulation, Mesenchymal stromal cells, Shear stress
1. Introduction
Mesenchymal stromal cells (MSCs) are multipotent osteoprogenitor cells capable of differentiation into a variety of cell types, including adipocytes, osteoblasts, and chondrocytes [1]. In addition to their differentiation potential, MSCs have been reported to regulate the immune response in many diseases through the production of various paracrine factors [2–5]. MSCs secrete a broad spectrum of soluble factors that can alter the local milieu by contributing to angiogenesis, tissue repair, cytoprotection, native cell growth, and inflammatory suppression [6,7]. Chemokines, anti-inflammatory cytokines, growth factors and other bioactive molecules secreted by MSCs regulate function and behavior of macrophages and other immune cells [7,8]. Due to the reparative and regenerative properties of MSCs, therapeutic application of MSCs is being tested in a number of clinical trials for various indications including cardiovascular diseases [9,10], neurodegenerative diseases [11], transplantation-related rejection or complication [12–14], autoimmune diseases [15] and metabolic disorders [16,17]. However, the important therapeutic features of self-renewal, multipotentiality, and immune modulation of MSCs become limited when these cells are introduced into in vitro culture, and MSCs progressively senesce [18,19].
Under physiological conditions, all adherent cells are surrounded by an extracellular matrix (ECM), which provides support, trophic signaling and biophysical cues, eventually defining fundamental cell properties, including cell cycling, survival, paracrine activity, motility, homing behavior, and cell fate [20,21]. These native, inherently mechanical, environments direct stem cell differentiation and function [22]. For example, cell culture substrates and scaffolds with bio-inspired topographic features drive MSCs into spatial arrangements that regulate their morphology, stemness, and fate [23–25]. In a recent study, we demonstrated that bone marrow-derived MSCs exposed to wall shear stress (WSS) mimicking vascular biomechanical forces up-regulated anti-inflammatory mediators, including COX2, HO-1, and prostaglandin E2 (PGE2). Furthermore, MSCs treated ex vivo with shear stress exhibited enhanced neuroprotective and anti-inflammatory effects in the injured rat brain following traumatic brain injury [26]. These findings promise to provide new methods to improve potency of MSCs used in cellular therapy, yet the molecular mechanism that drives the activation of anti-inflammatory signaling downstream of shear stress is incompletely understood.
Using primary human bone marrow MSCs, we investigate the mechanisms that regulate key mediators of MSC anti-inflammatory function. We demonstrate that Ca2+, Akt, MAPK, and focal adhesion kinase (FAK) signaling rapidly respond to WSS and that FAK is a critical regulator of flow-induced COX2 protein expression. Importantly, FAK-COX2 signaling is required for MSC immunomodulatory function, as inhibition of FAK abrogates COX2 induction and the ability of MSCs to suppress inflammatory cytokine production by activated immune cells.
2. Materials and methods
2.1. Cell culture and pharmacological reagents
Bone marrow MSCs were derived from whole bone marrow from independent human donor (AllCells). Cells were isolated and maintained as described previously [26]. Briefly, enriched mononuclear cells by phase separation in Ficoll-Paque were resuspended for immediate expansion in complete culture medium consisting of MEM-α (Thermo Scientific), 20% fetal bovine serum (Atlanta Biologicals), 100 units/ml penicillin (Gibco), 100 µg/ml streptomycin (Gibco), and 2 mM l-glutamine (Gibco). Nonadherent cells were removed after 2 days. Adherent colonies were expanded further and frozen as Passage 1. Expression of cell surface markers defined by the International Society for Stem Cell Therapy, including CD90 (+), CD73 (+), CD45 (−), CD34 (−), HLADR (−), CD19 (−), and CD11b (−) was confirmed by flow cytometry [26,27]. Thawed MSCs were plated at 1× 105 cells/ml, and medium was changed every three days. At 80% confluence, cells were passaged into IBIDI channels (μ-slide VI 0.4) at a density of 3 × 106 cells/ml for biochemical analysis. Following attachment to the culture surface, media flow was applied to produce laminar shear stress of 15 dyn/cm2, as detailed in the Microfluidics section below. Complete MEM-α culture medium was used, with the exception of experiments requiring Ca2+ free media prepared as above with a different base medium (MEM media, no calcium, no glutamine; Thermo Scientific).
All compounds targeted to MSCs were added 30 min to 1 h prior to application of WSS, were present for the duration of WSS exposure, and were washed out with fresh media prior to further experimental procedures unless noted otherwise. BAPTA-AM (Tocris) was applied to cells at a concentration of 10 µM as an intracellular calcium chelator. EGTA (ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′,-tetraacetic acid, Acros Organics) was used at a concentration of 5 mM as an extracellular calcium chelator. Gd3+ (Gadolinium chloride, Tocris) was used at 30 µM to block ion channels. LY294002 (Cayman Chemical) was applied to cells at a concentration of 10 µM to inhibit PI3K. PF-562271 (Selleckchem) was used at 10 µM to block FAK. Specific inhibitors of EP2 (PF-04418948, Cayman Chemical) and EP4 (L-161,982, Cayman Chemical) were applied at 10 µM during MSC co-culture with splenocytes. The stabilized analog of PGE2 (dimethyl-PGE2, Cayman Chemical), EP2 selective agonist butaprost (Cayman Chemical), or the EP4 agonist TCS 2510 (Fisher Scientific) were added to splenocyte cultures at 10 µM.
2.2. Microfluidics
Microfluidics devices (6 channel μ-slide VI0.4, IBIDI LLC) were used in all experiments. Prior to seeding cells in the device, the channels were coated for 30 min using 100 µg/ml fibronectin (Invitrogen Life Sciences) at 37 °C. Human bone marrow MSCs were then seeded and allowed to attach for 18 h. Following attachment, shear stress was applied using a 12-roller peristaltic pump (REGLO analog MS4/12, Ismatec) at 15 dyn/cm2 for up to 6 h, as previously described [26]. Static controls were plated in microfluidic slides under no-flow conditions, with the exception of fluid movement associated with manual medium change.
2.3. RNA extraction and quantitative RT PCR
Total RNA was extracted from 90,000 cells with the RNeasy Micro Kit (Qiagen). Reverse transcription of RNA was performed using Applied Biosystems Multiscribe DNA polymerase, and Real-time Taqman PCR (Applied Biosystems) was performed in 10 µl reactions with primers provided by Applied Biosystems. For calculation of fold change, cycle thresholds (Ct) were determined using SDS 2.2.1 software (Applied Biosystems), and mRNA expression was normalized to GAPDH transcript and the control sample.
2.4. Calcium imaging
Cells were plated into IBIDI slides at a density of 106 cells/ml. After attachment, cells were washed with isotonic Tyrode's solution (139 mM NaCl, 3 mM KCl, 17 mM NaHCO3, 12mM d-glucose, 3 mM CaCl2, and 1 mM MgCl2) and incubated with the fluorescent calcium indicator 5 µM Fluo-4 AM (F14201; Invitrogen) in isotonic Tyrode's solution for 5 min at 37C. Fresh phenol red free MEM-α medium was applied, and cells were placed in an environmental chamber maintained at 37 °C, 5% CO2 for imaging. Successive images were collected at a 385-msec time interval for 77 s (201 images total) using MetaMorph v7.7.9.0 on an Olympus IX81 fluorescent microscope equipped with an Andor iXon X3 885 EMCCD camera. Shutter was left open for the duration of imaging for rapid acquisition of frames, with the tradeoff that continuous excitation accelerated photobleaching of the Fluo-4 AM signal [28]. WSS was applied 5 s after initiation of image acquisition and thus represents static culture at start time. Images were subsequently analyzed for integrated intensity using manual selection of individual cell boundaries (a region of interest, ROI) and calculated for the average fluorescence intensity / ROI (F) with arbitrary units (AU) using MetaMorph software. To account for variations in baseline F (AU) among cells on the same slide and greater variation in F across cells from independent experiments on different days, F at each time point was normalized to its initial (the first digital frame acquired for each experiment) fluorescence intensity (F0): (F − F0) / F0, as described in a previous study [29]. The normalized fluorescence response to WSS was characterized by quantifying the percentage of responding cells. Responding cells were defined as cells with a positive value after normalization. The percentage of cells per field of view was plotted during 77 s WSS. Videos were compiled for visualization purposes using Amira 6.1.1 software (LEI) using a bilateral filter and block face correction to smoothen and reduce slice-based intensity fluctuation. Static and WSS images were treated identically, with the exception that the Static intensity was increased post-acquisition to match the starting intensity of the WSS movie. A custom look up table was applied to colorize the videos.
2.5. Immunoblotting
Cells were harvested in RIPA cell lysis buffer (GenDepot, R4100-010) with protease (Thermo Scientific, 88665) and phosphatase inhibitor cocktail (Sigma, P5726). After protein determination by protein assay dye (BioRad, 5000006), normalized lysate sample amounts were mixed with Laemmli's SDS sample buffer (GenDepot, L1100-001) and separated by SDS/PAGE on poured 10% bis-acrylamide (BioRad, 161-0156) mini gels (Novex Cassette,1.0 mm, 10 well, Thermo Fisher, NC2010) with 4% stacking. Gels were then wet transferred onto a nitrocellulose membrane (0.45 µm, BioRad, 162-0115) and analyzed by Western blotting using West Pico chemiluminescent substrate (Thermo Scientific, 34080) or Li-cor WesternSure Premium substrate (Fisher, 50-489-552). Immunoblotting was prepared by standard procedures using rabbit anti-COX2 (Abcam, ab15191), rabbit anti-TSG6 (Abcam, ab128266), rabbit anti-IL1Ra (Abcam, ab124962), rabbit anti-heme oxygenase 1 (Abcam, ab13243), rabbit anti-phospho-Akt (Ser 473, Cell Signaling, 9271), rabbit anti-Akt (Cell Signaling, 9272), rabbit anti-phospho-p44/42 MAPK (ERK1/2, Thr202/Tyr204, Cell Signaling, 9101), rabbit anti-p42/44 MAPK (Cell Signaling, 9102), rabbit anti-FAK (Cell Signaling, 3285), rabbit anti-pFAK (Tyr397, Cell Signaling, 3283), and mouse anti-β-actin (Santa Cruz, sc-47778) antibodies. Gel images were scanned and the density of the protein bands was quantified as a ratio to the total protein or actin loading control by MCID Analysis 7.1 software (InterFocus Imaging Ltd.) for films or by Image Studio software for the Li-cor C-DiGit chemiluminescent blot scanner.
2.6. Immunofluorescence microscopy
MSCs were fixed on microfluidics channels in 4% paraformaldehyde for 15 min, washed with PBS, and stored overnight at 4 °C. Slides were permitted to come to room temperature the next morning, sticky channel overlays removed by single edge razor blade, and cells permeabilized in PBS with 0.2% Triton X-100 for 5 min at room temperature. Cells were incubated with Image-iT FX signal enhancer (Thermo Fisher, I36933) for 30 min at room temperature. Rabbit anti-pFAK polyclonal antibody (1:100 dilution, anti-pFAK Y397, Cell Signaling 3283S) was applied for labeling activated FAK for 1 h at room temperature in 2.5% BSA-0.1% Triton X-PBS. Slides were then washed with PBS. Cells were incubated with a 1:1000 dilution of goat anti-rabbit IgG Alexa Fluor 488 secondary antibody (Invitrogen, Cat. No. A11008) for 1 h and washed in PBS. Cells were subsequently incubated with 25 µM DRAQ5 for 30 min at room temperature. Coverslips were mounted with Prolong Gold (Invitrogen). Images were captured by a Leica TCS SP5 confocal microscope with a Leica 63 × oil objective lens (NA 1.4) and analyzed with LAS Advanced Fluorescence software (Leica) and ImageJ 1.50i (NIH) to measure fluorescence intensity of the green channel.
2.7. TNF-α suppression assay
Human bone marrow MSCs were cultured at a density of 2 × 105 cells/ml. Murine splenocytes were isolated from 2 to 4 month old C57BL/6 J mice for co-culture at 6 × 106 cells/ml with MSCs immediately after shear stress preconditioning. Briefly, spleen was mechanically dissociated by pushing through a 70-µm strainer, lysed in Red Blood Cell Lysing Buffer Hybri-Max (Sigma-Aldrich), quenched with 2% BSA in PBS and pushed through a 40-µm strainer, centrifuged to pellet and resuspended after PBS washes in medium for culture with MSCs. Splenocyte-MSC co-cultures were plated at a ratio of 30 to 1. Lipopolysaccharide (LPS; Sigma Aldrich) was applied at 1 µg/ml 30 min after plating. Following 18 h incubation, supernatant was collected and analyzed for TNF-α using the Mouse TNF-α Quantikine ELISA kit (R & D Systems) following standard R & D Systems protocol.
2.8. Statistical analyses
Independent experiments were conducted on different days with primary human bone marrow cell lines. All data were analyzed with SigmaPlot 12.5 for statistical significance and are reported as mean ± SEM. Parametric tests were used when data met assumptions of homoscedasticity and normality; otherwise, nonparametric tests were employed.
3. Results
3.1. Shear stress regulates anti-inflammatory factors independently of Ca2+ signaling
We recently reported that human bone marrow-derived MSCs respond to laminar shear stress by increased immune modulatory activity [26]. When used as a transient conditioning method ex vivo, shear stress enhanced potency of MSCs administered to rats to control inflammatory response in the brain following traumatic brain injury. To investigate the mechanotransduction signaling pathways responsible for the observed change in immunomodulatory function, MSCs were cultured in microfluidics capable of producing uniform laminar flow at a WSS of 15 dyn/cm2 typical of human arterial stresses. Consistent with previous observations, key mediators of MSC anti-inflammatory function, PTGS2, HMOX1, IL1RN, and TNFAIP6 genes, were significantly upregulated in MSCs exposed to WSS for 3 h and 6 h (Fig. 1A; n = 4; Kruskal-Wallis One Way ANOVA, P < 0.001). Among many signal transduction pathways induced by WSS, Ca2+ has been thought to play a role as a rapid responder to shear stress [29,30]. Thus, we measured Ca2+ signaling induced by WSS using a cell permeant dye that increases in fluorescence upon binding to Ca2+, Fluo-4 AM. Fluo-4 AM-loaded MSCs were monitored by time lapse imaging for changes in fluorescence during a period of 77 s of static culture or 5 s of static culture followed by a 77 s exposure to WSS with 15 dyn/cm2. Although Ca2+ flashes were observed within static conditions, exposure to WSS induced more intense signaling across a greater number of cells (Fig. 1B, C and Supplementary Video 1). Normalized fluorescence traces for each cell in the field of view (~30 cells) demonstrated the occurrence of transient fluorescent increases upon the onset of WSS. Elevated Ca2+ levels were sustained throughout the WSS exposure and could be truncated by several chelators or inhibitors of Ca2+ flux, including the cell permeant chelator BAPTA-AM, the extracellular Ca2+ chelator EGTA, and the ion channel inhibitor Gd3+ (Supplementary Fig. 1A). In hematopoietic stem and progenitor cells of the embryo, we found that WSS acted through a Ca2+ mediated pathway to increase production of PGE2, a metabolic product of arachidonic acid metabolism [31]. We have shown previously that therapeutic benefit of MSCs correlates with the secretion of PGE2 and is stimulated by WSS [26,32]. COX2, encoded by the PTGS2 gene, is the rate-limiting enzyme in PGE2 synthesis; thus, we tested the dependence of COX2 expression on cytosolic Ca2+ by sequestration with BAPTA-AM, the compound that was most effective at reducing cytosolic Ca2+ increase in MSCs (Supplementary Fig. 1B; Friedman Repeated Measures with Tukey multiple comparisons, P < 0.05). WSS increased COX2 protein level 6 h after initial exposure (Fig. 1D, E; n = 3, Two Way ANOVA with Holm-Sidak multiple comparisons, P < 0.01). Unlike embryonic tissues containing mixed cell types studied previously, WSS-dependent expression of COX2 was not significantly reduced by blocking Ca2+ with BAPTA-AM. This suggested that MSCs rely on Ca2+-independent mechanisms for COX2 upregulation in response to WSS.
Fig. 1. WSS regulates COX2 and HO-1 expression independently of Ca2+ signaling.
(A) Transcription of PTGS, HMOX1, IL1RN and TSG6 is stimulated by WSS at 3 h and 6 h (n = 4 independent experiments; Kruskal-Wallis One Way ANOVA, ***P < 0.001). (B) WSS triggers elevated levels of Ca2+ concentration (n = 4 independent experiments, > 3 replicates per experiment). WSS was initiated 5 s after image acquisition began. See also Supplementary Video 1. (C) Quantification of Fluo-4 AM intensity by MetaMorph software captures multiple spikes in calcium flux following application of WSS. Pastel traces represent Ca2+ levels in individual cells (n = 30 cells); whereas, bold traces (blue or red) represent the average intensity of values collected from individual cells. Note that y-axes are different scales to show small changes in static cultures. (D, E) WSS induces COX2 by 6 h WSS, which persists with 10 µM of BAPTA-AM treatment. BAPTA-AM significantly reduces expression of HO-1 and TSG-6 (n = 3, Two Way ANOVA with Holm-Sidak multiple comparisons, *P < 0.05, **P < 0.01). All data are represented as mean ± SEM. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
3.2. Akt is activated by flow but does not dictate COX2 expression
ERK and Akt are two well-known shear-responsive signaling molecules, and both kinases are quickly activated by WSS in endothelial cells [33,34]. ERK and Akt have been shown to be sensitive to mechanosensors such as caveolae, cadherins, cell-cell adhesion molecules, and Ca2+ signaling [33,35–38]. Fluid shear stress elevated PTGS2 expression in osteoblasts through activation of phosphatidylinositol 3-kinase (PI3K)-Akt [39], and was recently shown to induce COX2 expression and prostacyclin release from endothelial cells via a platelet endothelial cell adhesion molecule (PECAM-1)-PI3K-dependent pathway [40]. Thus, we hypothesized that PI3K/Akt may contribute to regulation of COX2 in MSCs. We first evaluated activation of ERK and Akt by WSS. WSS resulted in profound activating phosphorylation of Akt and ERK within 5 min to 1 h of WSS (Fig. 2A, B; n = 3, One Way ANOVA with Holm-Sidak multiple comparisons, P < 0.05). In contrast to a prior report in osteoblasts [39], phosphorylation of Akt was not significantly attenuated by BAPTA-AM treatment or culture in Ca2+-free medium, suggesting that Ca2+ signaling is not the chief regulator of Akt and ERK activation by WSS in MSCs (Supplementary Fig. 2). To investigate whether Akt contributes to increased COX2 expression, the PI3K inhibitor LY294002 was applied for 30 min before and throughout the duration of WSS. As shown in Fig. 2C and D, LY294002 did not significantly reduce the expression of COX2. We conclude that PI3K/Akt does not play a major role in WSS-mediated upregulation of COX2 in MSCs.
Fig. 2. WSS-induced Akt activity is not responsible for COX2 increase.
(A, B) Phosphorylation of Akt and ERK occurs rapidly in response to flow (n = 3, One Way ANOVA with Holm-Sidak multiple comparisons, *P < 0.05). (C, D) Treatment with the PI3K inhibitor LY294002 at 10 µM fails to block COX2 increase in WSS-treated MSCs (n = 3, Kruskal Wallis ANOVA with Tukey multiple comparisons, *P < 0.05). All data are represented as mean ± SEM.
3.3. Activation of FAK promotes induction of COX2
Focal adhesions serve as organizing centers for signaling machinery that transduces information from the outside of the cell into chemical and genetic messages that are interpreted within the cytoplasm and nucleus. The tyrosine kinase FAK is one of many constituents that localize to focal adhesions, where integrins, actin, and various other scaffolding molecules, GTPases, and enzymes such as kinases, phosphatases, proteases, and lipases gather and interact [41]. FAK has been shown in previous reports to be required for shear-induced PTGS2 and COX2 in endothelium and osteoblasts [39,40]. We therefore hypothesized that FAK might also mediate COX2 mechanoresponse in MSCs. Autophosphorylation of FAK at Tyr 397 (pFAK-Y397) indicative of the first stages of FAK activation appeared elevated within 5 min of WSS initiation by immunofluorescence microscopy (Fig. 3A). To quantitatively assess change in FAK phosphorylation, pFAK-Y397 signal intensity was measured and the percentage of cells exhibiting clustering of pFAK were determined. WSS produced marked change in the distribution of pFAK, leading to a significant level of clustering by 6 h after initiation of flow (Fig. 3B; Kruskal Wallis ANOVA with Tukey multiple comparisons, P < 0.05). Overall expression of pFAK was only modestly elevated and was less dramatic than the assembly of pFAK clusters. Phosphorylated FAK-Y397 was also compared to total FAK levels in static culture and at 5 min, 30 min, and 6 h after WSS initiation by Western blotting. Measurement of pFAK-Y397 showed no increase as determined by immunoblotting of total protein in the cell population. Notwithstanding the lack of overall pFAK increase, the FAK inhibitor PF-562271 reduced pFAK-Y397 in static and WSS cultures (Fig. 3C, D; n = 3, Two Way ANOVA with Holm-Sidak multiple comparisons, P < 0.001) and blocked flow-induced upregulation of COX2 and HO-1 expression at 6 h (n= 4, unpaired t-test, P < 0.05). Thus, although pFAK-Y397 levels do not appear to be significantly increased, confocal immunofluorescence and FAK inhibitor studies strongly suggest that FAK is a critical regulator of COX2 expression in response to flow. Cells cultured in suspension also showed reduction in phosphorylation of FAK and COX2 protein levels, further supporting the importance of focal adhesions in control of COX2 expression. Together, these data show that FAK is required for COX2 regulation by fluid flow.
Fig. 3. FAK mediates induction of COX2 by flow.
(A) Phosphorylated FAK-Y397 is detectable as prominent clusters after exposure to flow. Scale bar represents 50 µm. (B) Quantification of pFAK-Y397 photomicrographs reveals increased clustering and signal intensity following WSS, suggesting that pFAK subcellular localization is altered (Kruskal Wallis ANOVA with Tukey multiple comparisons, *P < 0.05). (C, D) The FAK inhibitor PF-5662271 (10 µM) blocked FAK phosphorylation (n =3, Two Way ANOVA with Holm-Sidak multiple comparisons, ***P < 0.001). FAK inhibition also impaired the ability of WSS to elevate COX2 and HO-1 protein levels at 6 h (n = 4, unpaired t-test, *P < 0.05). Cells cultured in suspension for 1 h (labeled as Susp or S) displayed reduction in pFAK and COX2 relative to static cultured cells treated with vehicle (n = 3, unpaired t-test, ***P < 0.001). All data are represented as mean ± SEM.
3.4. Immunomodulatory activity of MSCs requires FAK signaling
FAK is known to influence actomyosin contractility, migration, cell survival, proliferation, angiogenesis, and invasive behaviors [41,42]. Our data raised the possibility that FAK might also direct immune regulatory functions of MSCs through signaling that governs COX2-PGE2 activity. To evaluate the effects of a FAK-initiated signaling cascade on MSC immunomodulatory function, we established co-cultures of human bone marrow MSCs with murine immune cells isolated from the spleen as described previously [26]. Immune cells from the spleen consisting of macrophages, neutrophils, NK, B, and T cells were stimulated with lipopolysaccharide (LPS) and monitored for pro-inflammatory TNF-α cytokine production. TNF-α is predominantly produced by activated M1-type macrophages but other immune cells can also produce TNF-α, including CD4+ T cells and NK cells. Following 18 h co-culture with LPS, species-specific ELISA was used to measure TNF-α originating from the murine splenocytes. LPS-treated splenocytes were activated to produce large amounts of TNF-α (Fig. 4A). Ectopic administration of a stabilized analog of PGE2 (dimethyl-PGE2), the EP2 selective agonist butaprost, or the EP4 agonist TCS 2510 were highly effective in reducing TNF-α secretion by splenocytes (Fig. 4A; n = 3, Two Way ANOVA with Holm-Sidak multiple comparisons, P < 0.001). In parallel assays, MSCs were cultured under static conditions or were transiently exposed to WSS for 3 h, then placed in co-culture with activated splenocytes. TNF-α secretion was significantly reduced by interactions with MSCs, regardless of mechanical preconditioning (Fig. 4A; n = 6, Two Way ANOVA with Holm-Sidak multiple comparisons, P < 0.001). We found that preconditioning of MSCs with WSS for 3 h enhanced potency in TNF-α suppression beyond that of static cultured MSCs (Fig. 4A; n = 6, Mann-Whitney Rank Sum test, P < 0.05). Importantly, inactivation of FAK signaling by treatment with PF-5622771 truncated the enhanced anti-inflammatory activity of shear-preconditioned MSCs, rendering the potency similar to that of static cultured MSCs. Selective inhibitors of the PGE2 G-protein coupled membrane receptors EP2 (PF-04418948) and EP4 (L-161,982) produced similar reductions in potency. Taken together, we conclude that FAK-COX2 signaling plays a critical role in MSC immunomodulatory function and propose a model of mechanotransduction that enhances immune regulatory activity of MSCs in response to shear stress (Fig. 4B).
Fig. 4. Inflammatory cytokine suppression by MSCs requires FAK-dependent COX2-PGE2 signaling.
(A) PGE2-EP2/4 receptor signaling determines MSC potency in suppression of inflammatory cytokine expression by LPS-stimulated immune cells from murine spleen. TNF-α suppression is normalized to fold reduction relative to fully activated splenocytes not placed in co-culture with MSCs. Treatment of splenocyte cultures with agonists of EP2/EP4 PGE2 receptors, static cultured MSCs, or WSS-cultured MSCs significantly reduced the ability of activated immune cells to secrete TNF-α Two Way ANOVA, ***P < 0.001. Comparison between static and WSS cultures treated with vehicle control revealed enhanced immunomodulatory activity following transient exposure to shear stress (n = 6, Mann-Whitney Rank Sum test, *P < 0.05). Inhibition of FAK (PF-562271), EP2 (PF-04418948), or EP4 (L-161,982) signaling blocked WSS enhancement in MSC function. All data are represented as mean ± SEM. (B) WSS enhances the immunomodulatory properties of MSCs via a focal adhesion-dependent pathway. Schematic depicts a working model of mechanotransduction downstream of WSS which includes activation of FAK at focal adhesions. Phosphorylated FAK stimulates MSC anti-inflammatory activity by intermediate transcription factor(s) that transactivate PTGS2. Ca2+ influx and activation of PI3K/Akt and MAPK could contribute to MSC immune regulatory function, though these signaling mechanisms remain largely unstudied.
4. Discussion
In the present study, we show that flow initiates a FAK-COX2 signaling cascade required for MSC immunomodulatory activity. This signaling is critical for the ability of MSCs to suppress pro-inflammatory cytokine production by inflammatory cells. Our study demonstrates that WSS induces influx of intracellular free calcium and activation of FAK, Akt, and MAPK in MSCs. Inhibition of Ca2+ transients by treatment with chelators, an ion channel blocker, or culture in Ca2+ free medium fails to block COX2 induction. Importantly, compound-based inhibition of FAK reduces COX2 expression, along with concomitant decrease in TNF-α suppression potency. Targeting receptors of one of the chief mediators of MSC immune regulatory function, PGE2, also interrupted the ability of MSCs to suppress immune cell activation. Together, these data highlight the importance of focal adhesions in the MSC response to shear stress and in MSC immunomodulatory function via COX2-PGE2 paracrine signaling.
Shear stress is sensed and translated into biochemical signals by various mechanosensors, including adhesion molecules like integrin [43] and PECAM-1 [44], GTP-binding proteins [45], caveolae [33], glycocalyx [46], and ion channels [47]. Protein tyrosine kinases such as FAK play a central role in translating integrin signals into chemical and genetic responses and can be found co-clustered at focal adhesions [48]. We find that WSS of 15 dyn/cm2 alters clustering and distribution of pFAK-Y397 in MSCs. Unlike the apparent change at the subcellular level by microscopy, immunoblotting analysis failed to detect an overall upregulation in phosphorylated FAK. FAK has been shown previously to be phosphorylated within one to several minutes after initial exposure to fluid shear stress, but it is also apparent that the subcellular localization of pFAK is critical to its function [49]. Importantly, our data show that inhibition of FAK truncates the flow-enhanced immunomodulatory activity of MSCs and blocks the induction of COX2. Complete inhibition of flow-induced COX2 was unique to the FAK inhibitor, as targeting other mechanosensitive pathways such as Ca2+ and PI3K/Akt failed to significantly reduce COX2 expression. One caveat to these experiments is the potential for off-target effects of PF-5622771, a risk inherent to any pharmacological approach. Yet, PF-5622771 is one of the most highly selective and potent inhibitors of FAK available, with > 10–100-fold selectivity to FAK over Pyk2 tyrosine kinase and cyclin dependent kinases (CDK1, 2, and 3), targets with little evidence in the literature for COX2 regulatory roles. Together, these data strongly suggest that signaling at focal adhesions is important for the capacity of MSCs to regulate COX2 and the immune system.
A diverse range of mitogenic and stress stimuli modulate PTGS2 mRNA abundance through transcriptional activation and RNA decay [50]. Although sensing of extracellular Ca2+ modulates transcriptional induction of COX2 in osteoblasts and fibroblasts [51–53], we did not observe any significant effects of intracellular Ca2+ transients on COX2 abundance. Instead, we show that COX2 expression is dependent upon FAK signaling, which elevates PTGS2 transcript and COX2 protein. PTGS2 mRNA is quickly degraded and its stability is regulated by RNA binding proteins that recognize elements in the 3′-untranslated region (3′UTR) of the PTGS2 transcript [50]. Src-family kinases can be activated by FAK-Y397 phosphorylation or directly by integrin clustering before and independently of FAK activation [54]. Interestingly, stabilization of PTGS2 mRNA has been shown to rely on Src, which phosphorylates the RNA-binding protein CUGBP2 to enhance its interaction with AU-rich regions in the PTGS2 3′UTR [55]. Enforced expression of CUGBP2 or constitutively active c-Src leads to stabilization of COX2. FAK also is also directly linked to COX2 transcriptional regulation in mechanically stressed human periodontal ligament cells, thereby promoting PGE2 production through control of COX2 abundance [56]. The intermediate transcription factor(s) responsible for increased COX2 in MSCs has not yet been identified. In our prior report, we showed that inhibition of NF-κB blocks shear stress-enhancement of MSC immunomodulatory activity [26]. NF-κB and AP-1 transcriptional complexes have well-documented roles downstream of shear stress and have been found to be regulated by FAK and Src [57–59]. Consistent with the notion that NF-κB may contribute to flow-induced COX2 regulation by a FAK signaling cascade, FAK has been shown to be required for fluid shear stress-induced degradation of NF-κB inhibitors IκBα and IκBβ and subsequent NF-κB nuclear localization in osteoblasts and endothelium [59,60]. Future studies will be required to fully elucidate the key transcriptional regulators in the FAK-COX2 pathway. It is likely, however, that NF-κB, C/EBP, AP-1, CREB, and other transcription factors [61] work in concert to dictate the expression of a repertoire of growth factors, cytokines, and kinases that reinforce anti-inflammatory functions of MSCs [62].
We also found that WSS stimulated ERK phosphorylation, consistent with previous studies that have implicated the MAPK pathway as an important intracellular signaling component of WSS-induced mechanotransduction in human MSCs [63,64]. A body of literature shows that MAPK-ERK signaling plays roles in mediating differentiation of MSCs by growth factor-based methods and by mechanical approaches [63,65–67]. Other kinases, such as p38 MAPK and Akt, are primarily associated with immunomodulatory function and tissue repair properties of MSCs [68,69]. Indeed, decreased phosphorylation activity of p38 MAPK caused decline in performance of aged MSCs via reduced production of PGE2 [68]. Interestingly, ectopic expression of any of the MAP kinases (ERK, JNK, or p38) can induce expression of PTGS2 transcript in fibroblasts [70]. We have not directly examined the contribution of MAPK to enhanced production of PGE2 in the MSC response to flow. Since MAPK lies downstream of FAK and MAPK has been directly linked to COX2 upregulation in other contexts, it is likely that MAPK and other regulators of transcription and RNA stability converge to determine COX2 abundance in response to the mechanical stress described in the current study. We speculate also that the MAPK signaling cascade could represent initiation of an early program of differentiation toward osteoblastic fate, and the long-term implications for lineage maturation of a transient WSS exposure will require more careful examination in future work.
Various therapeutic applications expose MSCs to distinct mechanical environments. Expansion, preconditioning, delivery, encapsulation, and the target organ present different forces and physical features that could alter potency via mechanotransduction pathways such as those described in the present study. Heterogeneity in the MSC population and donor variability are persistent challenges in clinical use of MSCs [71]. The present study identifies molecular rationale for how mechanical preconditioning could be utilized to improve therapeutic efficacy of MSCs in clinical applications and has revealed new possibilities for enhancement in the reparative potential of MSCs. Priorities for future studies will lie in understanding the role of biophysical cues in determination of the intracellular signaling that supports other mediators of MSC immune regulatory function, and whether aspects of mechanobiology will create further disparity in MSC performance or can be leveraged to produce greater consistency in MSC potency.
5. Conclusions
Collectively, our data support a role for fluid flow in modulation of the capacity of MSCs to suppress inflammatory response of the immune system. Force associated with flow promotes induction of COX2-PGE2 signaling, which is essential for flow-enhanced potency in suppression of TNF-α inflammatory cytokine production by immune cells. Several mechanosensors are activated by flow in MSCs, but FAK is a chief regulator of COX2 expression and thus plays a critical role in MSC immunomodulatory activity.
Supplementary Material
Acknowledgments
We thank Zhengmei Mao for microscopy support and video production. This work was supported by the State of Texas Emerging Technology Fund, American Society of Hematology Scholar Award, Mission Connect: a Program of the TIRR Foundation [14-121, 16-118], and the National Institutes of Health [K01DK092365].
C.S.C. and P.L.W. are inventors on a patent for conditioning of stem and progenitor stem cells for cellular therapy (US 62/183,273).
Abbreviations
- MSC
mesenchymal stromal cell
- FAK
focal adhesion kinase
- WSS
wall shear stress
Footnotes
Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.cellsig.2017.06.012.
Contributors
H.J.L. and P.L.W. designed the study and methodology. H.J.L., M.F.D., and A.E. completed the experiments and analyzed the data. S.D.O. and C.S.C. provided guidance on experimental design and direction. H.J.L. and P.L.W. wrote the manuscript and made final corrections prior to submission. All authors read and approved the final article.
Disclosure of potential conflicts of interest
All other authors declare no conflict of interest.
References
- 1.Bianco P, Cao X, Frenette PS, Mao JJ, Robey PG, Simmons PJ, Wang CY. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat. Med. 2013;19:35–42. doi: 10.1038/nm.3028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.English K. Mechanisms of mesenchymal stromal cell immunomodulation. Immunol. Cell Biol. 2013;91:19–26. doi: 10.1038/icb.2012.56. [DOI] [PubMed] [Google Scholar]
- 3.Prockop DJ, Oh JY. Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol. Ther. 2012;20:14–20. doi: 10.1038/mt.2011.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Shi Y, Su J, Roberts AI, Shou P, Rabson AB, Ren G. How mesenchymal stem cells interact with tissue immune responses. Trends Immunol. 2012;33:136–143. doi: 10.1016/j.it.2011.11.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Wagner J, Kean T, Young R, Dennis JE, Caplan AI. Optimizing mesenchymal stem cell-based therapeutics. Curr. Opin. Biotechnol. 2009;20:531–536. doi: 10.1016/j.copbio.2009.08.009. [DOI] [PubMed] [Google Scholar]
- 6.Bassi ÊJ, de Almeida DC, Moraes-Vieira PM, Câmara NO. Exploring the role of soluble factors associated with immune regulatory properties of mesenchymal stem cells. Stem Cell Rev. 2012;8:329–342. doi: 10.1007/s12015-011-9311-1. [DOI] [PubMed] [Google Scholar]
- 7.Ma S, Xie N, Li W, Yuan B, Shi Y, Wang Y. Immunobiology of mesenchymal stem cells. Cell Death Differ. 2014;21:216–225. doi: 10.1038/cdd.2013.158. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Eggenhofer E, Hoogduijn MJ. Mesenchymal stem cell-educated macrophages. Transplant. Res. 2012;1:12. doi: 10.1186/2047-1440-1-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Kuraitis D, Ruel M, Suuronen EJ. Mesenchymal stem cells for cardiovascular regeneration. Cardiovasc. Drugs Ther. 2011;25:349–362. doi: 10.1007/s10557-011-6311-y. [DOI] [PubMed] [Google Scholar]
- 10.Singh A, Singh A, Sen D. Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010–2015) Stem Cell Res Ther. 2016;7:82. doi: 10.1186/s13287-016-0341-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Joyce N, Annett G, Wirthlin L, Olson S, Bauer G, Nolta JA. Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen. Med. 2010;5:933–946. doi: 10.2217/rme.10.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Ball LM, Bernardo ME, Roelofs H, Lankester A, Cometa A, Egeler RM, Locatelli F, Fibbe WE. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood. 2007;110:2764–2767. doi: 10.1182/blood-2007-04-087056. [DOI] [PubMed] [Google Scholar]
- 13.Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger M, Dini G, Egeler RM, Bacigalupo A, Fibbe W, Ringdén O. Developmental Committee of the European Group for Blood and Marrow Transplantation, Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008;371:1579–1586. doi: 10.1016/S0140-6736(08)60690-X. [DOI] [PubMed] [Google Scholar]
- 14.Pérez-Simon JA, López-Villar O, Andreu EJ, Rifón J, Muntion S, Diez Campelo M, Sánchez-Guijo FM, Martinez C, Valcarcel D, Cañizo CD. Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial. Haematologica. 2011;96:1072–1076. doi: 10.3324/haematol.2010.038356. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Rafei M, Campeau PM, Aguilar-Mahecha A, Buchanan M, Williams P, Birman E, Yuan S, Young YK, Boivin MN, Forner K, Basik M, Galipeau J. Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner. J. Immunol. 2009;182:5994–6002. doi: 10.4049/jimmunol.0803962. [DOI] [PubMed] [Google Scholar]
- 16.Jiang R, Han Z, Zhuo G, Qu X, Li X, Wang X, Shao Y, Yang S, Han ZC. Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study. Front. Med. 2011;5:94–100. doi: 10.1007/s11684-011-0116-z. [DOI] [PubMed] [Google Scholar]
- 17.Vanikar AV, Dave SD, Thakkar UG, Trivedi HL. Cotransplantation of adipose tissue-derived insulin-secreting mesenchymal stem cells and hematopoietic stem cells: a novel therapy for insulin-dependent diabetes mellitus. Stem Cells Int. 2010;2010:582382. doi: 10.4061/2010/582382. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Conget PA, Minguell JJ. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J. Cell. Physiol. 1999;181:67–73. doi: 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO;2-C. [DOI] [PubMed] [Google Scholar]
- 19.Digirolamo CM, Stokes D, Colter D, Phinney DG, Class R, Prockop DJ. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br. J. Haematol. 1999;107:275–281. doi: 10.1046/j.1365-2141.1999.01715.x. [DOI] [PubMed] [Google Scholar]
- 20.Lee HJ, Li N, Evans SM, Diaz MF, Wenzel PL. Biomechanical force in blood development: extrinsic physical cues drive pro-hematopoietic signaling. Differentiation. 2013;86:92–103. doi: 10.1016/j.diff.2013.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Sun Y, Chen CS, Fu J. Forcing stem cells to behave: a biophysical perspective of the cellular microenvironment. Annu. Rev. Biophys. 2012;41:519–542. doi: 10.1146/annurev-biophys-042910-155306. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell. 2006;126:677–689. doi: 10.1016/j.cell.2006.06.044. [DOI] [PubMed] [Google Scholar]
- 23.Rodriguez-Lorenzo LM, Saldaña L, Benito-Garzón L, García-Carrodeguas R, de Aza S, Vilaboa N, Román JS. Feasibility of ceramic-polymer composite cryogels as scaffolds for bone tissue engineering. J. Tissue Eng. Regen. Med. 2012;6:421–433. doi: 10.1002/term.443. [DOI] [PubMed] [Google Scholar]
- 24.Wei J, Han J, Zhao Y, Cui Y, Wang B, Xiao Z, Chen B, Dai J. The importance of three-dimensional scaffold structure on stemness maintenance of mouse embryonic stem cells. Biomaterials. 2014;35:7724–7733. doi: 10.1016/j.biomaterials.2014.05.060. [DOI] [PubMed] [Google Scholar]
- 25.Wang M, Cheng X, Zhu W, Holmes B, Keidar M, Zhang LG. Design of biomimetic and bioactive cold plasma-modified nanostructured scaffolds for enhanced osteogenic differentiation of bone marrow-derived mesenchymal stem cells. Tissue Eng. Part A. 2014;20:1060–1071. doi: 10.1089/ten.TEA.2013.0235. [DOI] [PubMed] [Google Scholar]
- 26.Diaz MF, Vaidya AB, Evans SM, Lee HJ, Aertker BM, Alexander AJ, Price KM, Ozuna JA, Liao GP, Aroom KR, Xue H, Gu L, Omichi R, Bedi S, Olson SD, Cox CS, Wenzel PL. Biomechanical forces promote immune regulatory function of bone marrow mesenchymal stromal cells. Stem Cells. 2017;35:1259–1272. doi: 10.1002/stem.2587. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–317. doi: 10.1080/14653240600855905. [DOI] [PubMed] [Google Scholar]
- 28.Bootman MD, Rietdorf K, Collins T, Walker S, Sanderson M. Ca2+-sensitive fluorescent dyes and intracellular Ca2+ imaging. Cold Spring Harb Protoc. 2013;2013:83–99. doi: 10.1101/pdb.top066050. [DOI] [PubMed] [Google Scholar]
- 29.Scheitlin CG, Julian JA, Shanmughapriya S, Madesh M, Tsoukias NM, Alevriadou BR. Endothelial mitochondria regulate the intracellular Ca2+ response to fluid shear stress. Am. J. Phys. Cell Physiol. 2016;310:C479–C490. doi: 10.1152/ajpcell.00171.2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Yamamoto K, Korenaga R, Kamiya A, Ando J. Fluid shear stress activates Ca2+ influx into human endothelial cells via P2X4 purinoceptors. Circ. Res. 2000;87:385–391. doi: 10.1161/01.res.87.5.385. [DOI] [PubMed] [Google Scholar]
- 31.Diaz MF, Li N, Lee HJ, Adamo L, Evans SM, Willey HE, Arora N, Torisawa YS, Vickers DA, Morris SA, Naveiras O, Murthy SK, Ingber DE, Daley GQ, García-Cardeña G, Wenzel PL. Biomechanical forces promote blood development through prostaglandin E2 and the cAMP-PKA signaling axis. J. Exp. Med. 2015;212:665–680. doi: 10.1084/jem.20142235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Kota DJ, Prabhakara KS, Toledano-Furman N, Bhattarai D, Chen Q, DiCarlo B, Smith P, Triolo F, Wenzel PL, Cox CS, Olson SD. Prostaglandin E2 indicates therapeutic efficacy of mesenchymal stem cells in experimental traumatic brain injury. Stem Cells. 2017;35:1416–1430. doi: 10.1002/stem.2603. [DOI] [PubMed] [Google Scholar]
- 33.Boyd NL, Park H, Yi H, Boo YC, Sorescu GP, Sykes M, Jo H. Chronic shear induces caveolae formation and alters ERK and Akt responses in endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2003;285:H1113–H1122. doi: 10.1152/ajpheart.00302.2003. [DOI] [PubMed] [Google Scholar]
- 34.Ando J, Yamamoto K. Flow detection and calcium signalling in vascular endothelial cells. Cardiovasc. Res. 2013;99:260–268. doi: 10.1093/cvr/cvt084. [DOI] [PubMed] [Google Scholar]
- 35.Agella N, Bachsa O, Rocamorab N, Villalongaa P. Modulation of the Ras/Raf/MEK/ERK pathway by Ca2+, and calmodulin. Cell. Signal. 2002;14:649–654. doi: 10.1016/s0898-6568(02)00007-4. [DOI] [PubMed] [Google Scholar]
- 36.Danciu TE, Adam RM, Naruse K, Freeman MR, Hauschka PV. Calcium regulates the PI3K-Akt pathway in stretched osteoblasts. FEBS Lett. 2003;536:193–197. doi: 10.1016/s0014-5793(03)00055-3. [DOI] [PubMed] [Google Scholar]
- 37.Yasuoka C, Ihara Y, Ikeda S, Miyahara Y, Kondo T, Kohno S. Antiapoptotic activity of Akt is down-regulated by Ca2+ in myocardiac H9c2 cells: evidence of Ca2+-dependent regulation of protein phosphatase 2Ac. J. Biol. Chem. 2004;279:51182–51192. doi: 10.1074/jbc.M407225200. [DOI] [PubMed] [Google Scholar]
- 38.Tzima E, Irani-Tehrani M, Kiosses WB, Dejana E, Schultz DA, Engelhardt B, Cao G, DeLisser H, Schwartz MA. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature. 2005;437:426–431. doi: 10.1038/nature03952. [DOI] [PubMed] [Google Scholar]
- 39.Rangaswami H, Schwappacher R, Tran T, Chan GC, Zhuang S, Boss GR, Pilz RB. Protein kinase G and focal adhesion kinase converge on Src/Akt/β-catenin signaling module in osteoblast mechanotransduction. J. Biol. Chem. 2012;287:21509–21519. doi: 10.1074/jbc.M112.347245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Russell-Puleri S, dela Paz NG, Adams D, Chattopadhyay M, Cancel L, Ebong E, Orr AW, Frangos JA, Tarbell JM. Fluid shear stress induces upregulation of COX-2 and PGI2 release in endothelial cells via a pathway involving PECAM-1, PI3K, FAK, and p38. Am. J. Physiol. Heart Circ. Physiol. 2017;312:H485. doi: 10.1152/ajpheart.00035.2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Wozniak MA, Modzelewska K, Kwong L, Keely PJ. Focal adhesion regulation of cell behavior. Biochim. Biophys. Acta, Mol. Cell Res. 2004;1692:103–119. doi: 10.1016/j.bbamcr.2004.04.007. [DOI] [PubMed] [Google Scholar]
- 42.Mitra SK, Schlaepfer DD. Integrin-regulated FAK–Src signaling in normal and cancer cells. Curr. Opin. Cell Biol. 2006;18:516–523. doi: 10.1016/j.ceb.2006.08.011. [DOI] [PubMed] [Google Scholar]
- 43.Wang N, Butler JP, Ingber DE. Mechanotransduction across the cell surface and through the cytoskeleton. Science. 1993;260:1124–1127. doi: 10.1126/science.7684161. [DOI] [PubMed] [Google Scholar]
- 44.Masuda M, Osawa M, Shigematsu H, Harada N, Fujiwara K. Platelet endothelial cell adehesion molecule-1 is a major SH-PTP2 binding protein in vascular endothelial cells. FEBS Lett. 1997;408:331–336. doi: 10.1016/s0014-5793(97)00457-2. [DOI] [PubMed] [Google Scholar]
- 45.Gudi SR, Clark CB, Frangos JA. Fluid flow rapidly activates G proteins in human endothelial cells: involvement of G proteins in mechanochemical signal transduction. Circ. Res. 1996;79:834–839. doi: 10.1161/01.res.79.4.834. [DOI] [PubMed] [Google Scholar]
- 46.Thi MM, Tarbell JM, Weinbaum S, Spray DC. The role of the glycocalyx in reorganization of the actin cytoskeleton under fluid shear stress: a “bumper-car” model. Proc. Natl. Acad. Sci. U. S. A. 2004;101:16483–16488. doi: 10.1073/pnas.0407474101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Sukharev S, Sachs F. Molecular force transduction by ion channels-diversity and unifying principles. J. Cell Sci. 2012;125:3075–3083. doi: 10.1242/jcs.092353. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Geiger B, Bershadsky A. Exploring the neighborhood: adhesion-coupled cell mechanosensors. Cell. 2002;110:139–142. doi: 10.1016/s0092-8674(02)00831-0. [DOI] [PubMed] [Google Scholar]
- 49.Li S, Kim M, Hu Y-L, Jalali S, Schlaepfer DD, Hunter T, Chien S, Shyy JYJ. Fluid shear stress activation of focal adhesion kinase: linking to mitogen-activated protein kinases. J. Biol. Chem. 1997;272:30455–30462. doi: 10.1074/jbc.272.48.30455. [DOI] [PubMed] [Google Scholar]
- 50.Hla T, Bishop-Bailey D, Liu CH, Schaefers HJ, Trifan OC. Cyclooxygenase-1 and-2 isoenzymes. Int. J. Biochem. Cell Biol. 1999;31:551–557. doi: 10.1016/s1357-2725(98)00152-6. [DOI] [PubMed] [Google Scholar]
- 51.Choudhary S, Kumar A, Kale RK, Raisz LG, Pilbeam CC. Extracellular calcium induces COX-2 in osteoblasts via a PKA pathway. Biochem. Biophys. Res. Commun. 2004;322:395–402. doi: 10.1016/j.bbrc.2004.07.129. [DOI] [PubMed] [Google Scholar]
- 52.Choudhary S, Wadhwa S, Raisz LG, Alander C, Pilbeam CC. Extracellular calcium is a potent inducer of cyclo-oxygenase-2 in murine osteoblasts through an ERK signaling pathway. J. Bone Miner. Res. 2003;18:1813–1824. doi: 10.1359/jbmr.2003.18.10.1813. [DOI] [PubMed] [Google Scholar]
- 53.Ogata S, Kubota Y, Satoh S, Ito S, Takeuchi H, Ashizuka M, Shirasuna K. Ca2+ stimulates COX-2 expression through calcium-sensing receptor in fibroblasts. Biochem. Biophys. Res. Commun. 2006;351:808–814. doi: 10.1016/j.bbrc.2006.10.098. [DOI] [PubMed] [Google Scholar]
- 54.Arias-Salgado EG, Lizano S, Sarkar S, Brugge JS, Ginsberg MH, Shattil SJ. Src kinase activation by direct interaction with the integrin β cytoplasmic domain. Proc. Natl. Acad. Sci. 2003;100:13298–13302. doi: 10.1073/pnas.2336149100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Xu K, Kitchen CM, Shu H-KG, Murphy TJ. Platelet-derived growth factor-induced stabilization of cyclooxygenase 2 mRNA in rat smooth muscle cells requires the c-Src family of protein-tyrosine kinases. J. Biol. Chem. 2007;282:32699–32709. doi: 10.1074/jbc.M705272200. [DOI] [PubMed] [Google Scholar]
- 56.Kang Y-G, Nam J-H, Kim K-H, Lee K-S. FAK pathway regulates PGE2 production in compressed periodontal ligament cells. J. Dent. Res. 2010;89:1444–1449. doi: 10.1177/0022034510378521. [DOI] [PubMed] [Google Scholar]
- 57.Davies PF. Flow-mediated endothelial mechanotransduction. Physiol. Rev. 1995;75:519–560. doi: 10.1152/physrev.1995.75.3.519. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Dai S, Abu-Amer W, Karuppaiah K, Abu-Amer Y. Evidence that the kinase-truncated c-Src regulates NF-κB signaling by targeting NEMO. J. Cell Biol. 2011;112:2463–2470. doi: 10.1002/jcb.23170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Petzold T, Orr AW, Hahn C, Jhaveri KA, Parsons JT, Schwartz MA. Focal adhesion kinase modulates activation of NF-κB by flow in endothelial cells. Am. J. Phys. Cell Phys. 2009;297:C814. doi: 10.1152/ajpcell.00226.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Young SRL, Gerard-O'Riley R, Harrington M, Pavalko FM. Activation of NF-κB by fluid shear stress, but not TNF-α, requires focal adhesion kinase in osteoblasts. Bone. 2010;47:74–82. doi: 10.1016/j.bone.2010.03.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Ogasawara A, Arakawa T, Kaneda T, Takuma T, Sato T, Kaneko H, Kumegawa M, Hakeda Y. Fluid shear stress-induced cyclooxygenase-2 expression is mediated by C/EBP β, cAMP-response element-binding protein, and AP-1 in osteoblastic MC3T3-E1 cells. J. Biol. Chem. 2001;276:7048–7054. doi: 10.1074/jbc.M008070200. [DOI] [PubMed] [Google Scholar]
- 62.Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM, Hu X, Jelinek I, Star RA, Mezey E. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 2009;15:42–49. doi: 10.1038/nm.1905. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Kim SH, Choi YR, Park MS, Shin JW, Park KD, Kim SJ, Lee JW. ERK 1/2 activation in enhanced osteogenesis of human mesenchymal stem cells in poly (lactic-glycolic acid) by cyclic hydrostatic pressure. J. Biomed. Mater. Res. A. 2007;80:826–836. doi: 10.1002/jbm.a.30945. [DOI] [PubMed] [Google Scholar]
- 64.Alexander LD, Alagarsamy S, Douglas JG. Cyclic stretch-induced cPLA2 mediates ERK 1/2 signaling in rabbit proximal tubule cells. Kidney Int. 2004;65:551–563. doi: 10.1111/j.1523-1755.2004.00405.x. [DOI] [PubMed] [Google Scholar]
- 65.Jaiswal RK, Jaiswal N, Bruder SP, Mbalaviele G, Marshak DR, Pittenger MF. Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J. Biol. Chem. 2000;275:9645–9652. doi: 10.1074/jbc.275.13.9645. [DOI] [PubMed] [Google Scholar]
- 66.Liu J, Zhao Z, Li J, Zou L, Shuler C, Zou Y, Huang X, Li M, Wang J. Hydrostatic pressures promote initial osteodifferentiation with ERK1/2 not p38 MAPK signaling involved. J. Cell Biol. 2009;107:224–232. doi: 10.1002/jcb.22118. [DOI] [PubMed] [Google Scholar]
- 67.Ng F, Boucher S, Koh S, Sastry KS, Chase L, Lakshmipathy U, Choong C, Yang Z, Vemuri MC, Rao MS, Tanavde V. PDGF, TGF-β, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood. 2008;112:295–307. doi: 10.1182/blood-2007-07-103697. [DOI] [PubMed] [Google Scholar]
- 68.Yu K-R, Lee JY, Kim H-S, Hong I-S, Choi SW, Seo Y, Kang I, Kim J-J, Lee B-C, Lee S, Kurtz A, Seo K-W, Kang K-S. A p38 MAPK-mediated alteration of COX-2/PGE2 regulates immunomodulatory properties in human mesenchymal stem cell aging. PLoS One. 2014;9:e102426. doi: 10.1371/journal.pone.0102426. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, Dzau VJ. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. 2003;9:1195–1201. doi: 10.1038/nm912. [DOI] [PubMed] [Google Scholar]
- 70.McGinty A, Foschi M, Chang Y-WE, Han J, Dunn MJ, Sorokin A. Induction of prostaglandin endoperoxide synthase 2 by mitogen-activated protein kinase cascades. Biochem. J. 2000;352:419–424. [PMC free article] [PubMed] [Google Scholar]
- 71.Phinney DG. Functional heterogeneity of mesenchymal stem cells: implications for cell therapy. J. Cell. Biochem. 2012;113:2806–2812. doi: 10.1002/jcb.24166. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.